3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma
2
Breast Neoplasms
2
Sarcoma
1
Preleukemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mobility Limitation
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphatic Diseases
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Diseases
1
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Nivolumab
3
Gemcitabine
3
cabozantinib
2
avelumab
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tremelimumab
1
tocilizumab
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Doxorubicin
1
Cystoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Patient Reported Outcome Measures
×
90 days
×
Clear all
No trials found.